mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-06 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
6e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |